Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(1R,6R,9S,12S,15S,18S,24S,30S,36S,39S,42S,45S,48S,54S,57S,62S)- 9,39-dibenzyl-15,30-bis[(2S)-butan-2-yl]-24-[(1R)-1- hydroxyethyl]-12-(hydroxymethyl)-42-[(4- hydroxyphenyl)methyl]-57-(1H-imidazol-5-ylmethyl)- 62-methyl- 8,11,14,17,23,26,29,32,35,38,41,44,47,53,56,59,61,64,67,70- icosaoxo-36,54-bis(propan-2-yl)-3,4-dithia- 7,10,13,16,22,25,28,31,34,37,40,43,46,52,55,58,60,63,66,69- icosaazatetracyclo[43.14.13.0^{18,22}.0^{48,52}]doheptacontane-6- carboxylic acid
ID: ALA1945675
PubChem CID: 57396162
Max Phase: Preclinical
Molecular Formula: C94H132N22O25S2
Molecular Weight: 2034.35
Molecule Type: Protein
Associated Items: